Published in J Am Chem Soc on March 13, 2014
An Integrated Framework Advancing Membrane Protein Modeling and Design. PLoS Comput Biol (2015) 0.84
Conformational Fine-Tuning of Pore-Forming Peptide Potency and Selectivity. J Am Chem Soc (2015) 0.80
Computational studies of peptide-induced membrane pore formation. Philos Trans R Soc Lond B Biol Sci (2017) 0.78
Determining the Effects of Membrane-Interacting Peptides on Membrane Integrity. Methods Mol Biol (2015) 0.77
Testing the limits of rational design by engineering pH sensitivity into membrane-active peptides. Biochim Biophys Acta (2015) 0.75
Development of a lytic peptide derived from BH3-only proteins. Cell Death Discov (2016) 0.75
Spontaneous formation of structurally diverse membrane channel architectures from a single antimicrobial peptide. Nat Commun (2016) 0.75
Ebola Virus Delta Peptide is a Viroporin. J Virol (2017) 0.75
The dawning era of polymer therapeutics. Nat Rev Drug Discov (2003) 7.86
Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta (1986) 7.07
Structure of a fluid dioleoylphosphatidylcholine bilayer determined by joint refinement of x-ray and neutron diffraction data. III. Complete structure. Biophys J (1992) 6.46
Mode of action of membrane active antimicrobial peptides. Biopolymers (2002) 4.74
A biosensor that uses ion-channel switches. Nature (1997) 4.05
Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J (2001) 3.80
Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water. Biopolymers (1991) 3.51
Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta (1998) 2.71
Neutron scattering in the plane of membranes: structure of alamethicin pores. Biophys J (1996) 2.63
Mode of action of the antimicrobial peptide indolicidin. J Biol Chem (1996) 2.57
Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci (1994) 2.43
Alamethicin: a peptide model for voltage gating and protein-membrane interactions. Annu Rev Biophys Biomol Struct (1994) 2.37
Orientation of melittin in phospholipid bilayers. A polarized attenuated total reflection infrared study. Biophys J (1991) 2.27
Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol (2010) 2.27
Folding of amphipathic alpha-helices on membranes: energetics of helix formation by melittin. J Mol Biol (1999) 2.06
Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue. Biophys J (1982) 2.03
Structure, location, and lipid perturbations of melittin at the membrane interface. Biophys J (2001) 1.96
Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta (2006) 1.93
Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry (1990) 1.86
Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J Clin Invest (2009) 1.78
Energetics of pore formation induced by membrane active peptides. Biochemistry (2004) 1.77
Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys J (1997) 1.76
Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry (2009) 1.72
Melittin: a membrane-active peptide with diverse functions. Biosci Rep (2007) 1.70
'Detergent-like' permeabilization of anionic lipid vesicles by melittin. Biochim Biophys Acta (2001) 1.53
Leakage of membrane vesicle contents: determination of mechanism using fluorescence requenching. Biophys J (1995) 1.47
Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes. J Am Chem Soc (2008) 1.46
Spontaneous membrane-translocating peptides by orthogonal high-throughput screening. J Am Chem Soc (2011) 1.35
pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry (1987) 1.27
Critical role of lipid composition in membrane permeabilization by rabbit neutrophil defensins. J Biol Chem (1997) 1.26
Probing the "charge cluster mechanism" in amphipathic helical cationic antimicrobial peptides. Biochemistry (2010) 1.24
Structure of the alamethicin pore reconstructed by x-ray diffraction analysis. Biophys J (2008) 1.24
Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog. Biochemistry (1997) 1.18
Pores formed by Baxα5 relax to a smaller size and keep at equilibrium. Biophys J (2010) 1.16
The history of alamethicin: a review of the most extensively studied peptaibol. Chem Biodivers (2007) 1.15
Anticancer and chemosensitizing abilities of cycloviolacin 02 from Viola odorata and psyle cyclotides from Psychotria leptothyrsa. Biopolymers (2010) 1.13
Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes. Biochemistry (2007) 1.12
Kinetic pathway of antimicrobial peptide magainin 2-induced pore formation in lipid membranes. J Phys Chem B (2010) 1.10
Process of inducing pores in membranes by melittin. Proc Natl Acad Sci U S A (2013) 1.09
Interactions of monomeric rabbit neutrophil defensins with bilayers: comparison with dimeric human defensin HNP-2. Biochemistry (1996) 1.03
Gramicidin channels in phospholipid bilayers with unsaturated acyl chains. Biophys J (1997) 1.02
Cytolytic nanoparticles attenuate HIV-1 infectivity. Antivir Ther (2012) 1.02
Magainin 2-induced pore formation in the lipid membranes depends on its concentration in the membrane interface. J Phys Chem B (2009) 1.01
Association of a pH-sensitive peptide with membrane vesicles: role of amino acid sequence. Biochemistry (1990) 0.98
Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. J Pept Sci (2005) 0.97
Determining the mechanism of membrane permeabilizing peptides: identification of potent, equilibrium pore-formers. Biochim Biophys Acta (2012) 0.96
Gain-of-function analogues of the pore-forming peptide melittin selected by orthogonal high-throughput screening. J Am Chem Soc (2012) 0.95
A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. J Control Release (2012) 0.95
Membranolytic selectivity of cystine-stabilized cyclic protegrins. Eur J Biochem (2000) 0.94
A membrane-translocating peptide penetrates into bilayers without significant bilayer perturbations. Biophys J (2013) 0.91
Dual-color fluorescence-burst analysis to study pore formation and protein-protein interactions. Methods (2008) 0.88
The electrical response of bilayers to the bee venom toxin melittin: evidence for transient bilayer permeabilization. Biochim Biophys Acta (2013) 0.88
Secondary structure and orientation of the amphipathic peptide GALA in lipid structures. An infrared-spectroscopic approach. Eur J Biochem (1991) 0.87
Effect of a polymer cushion on the electrical properties and stability of surface-supported lipid bilayers. Langmuir (2010) 0.87
Investigation of model membrane disruption mechanism by melittin using pulse electron paramagnetic resonance spectroscopy and cryogenic transmission electron microscopy. J Phys Chem B (2011) 0.87
Penetration of the insect defensin A into phospholipid monolayers and formation of defensin A-lipid complexes. Biophys J (1997) 0.87
Electrical measurements of bilayer membranes formed by Langmuir-Blodgett deposition on single-crystal silicon. Langmuir (2007) 0.85
Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles. Biophys J (2000) 0.85
Interactions of membrane active peptides with planar supported bilayers: an impedance spectroscopy study. Langmuir (2012) 0.84
Synthetic molecular evolution of pore-forming peptides by iterative combinatorial library screening. ACS Chem Biol (2013) 0.83
Structural and biophysical properties of a synthetic channel-forming peptide: designing a clinically relevant anion selective pore. Biochim Biophys Acta (2011) 0.79
Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes (2002) 10.49
Evaluation of tumor-size response metrics to predict overall survival in Western and Chinese patients with first-line metastatic colorectal cancer. J Clin Oncol (2013) 5.55
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes (2005) 4.31
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 3.83
The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer (2011) 3.42
A perinuclear actin cap regulates nuclear shape. Proc Natl Acad Sci U S A (2009) 3.12
Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol (2011) 2.44
Multifunctional nanorods for gene delivery. Nat Mater (2003) 2.09
Uterine massage to reduce blood loss after vaginal delivery: a randomized controlled trial. Obstet Gynecol (2013) 1.96
Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry (2006) 1.96
The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Res (2006) 1.94
MPEx: a tool for exploring membrane proteins. Protein Sci (2009) 1.89
Antimicrobial peptides: successes, challenges and unanswered questions. J Membr Biol (2011) 1.83
Forster resonance energy transfer in liposomes: measurements of transmembrane helix dimerization in the native bilayer environment. Anal Biochem (2005) 1.81
Exome sequencing generates high quality data in non-target regions. BMC Genomics (2012) 1.72
Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO J (2009) 1.70
Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells. Proc Natl Acad Sci U S A (2013) 1.62
FGFR3 dimer stabilization due to a single amino acid pathogenic mutation. J Mol Biol (2005) 1.59
Critical mechanical conditions around neovessels in carotid atherosclerotic plaque may promote intraplaque hemorrhage. Atherosclerosis (2012) 1.56
Genome of the Chinese tree shrew. Nat Commun (2013) 1.55
Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. J Am Chem Soc (2009) 1.53
Postnatal intracerebroventricular exposure to neuropeptide Y causes weight loss in female adult rats. Am J Physiol Regul Integr Comp Physiol (2003) 1.51
Common variants in HSPB7 and FRMD4B associated with advanced heart failure. Circ Cardiovasc Genet (2010) 1.51
Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis (2006) 1.49
Factors influencing the removal of fluoride from aqueous solution by calcined Mg-Al-CO3 layered double hydroxides. J Hazard Mater (2005) 1.49
Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. Endocrinology (2006) 1.46
PEG-based hydrogels as an in vitro encapsulation platform for testing controlled beta-cell microenvironments. Acta Biomater (2005) 1.46
Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes. J Am Chem Soc (2008) 1.46
Peregrine and saker falcon genome sequences provide insights into evolution of a predatory lifestyle. Nat Genet (2013) 1.45
Measuring the energetics of membrane protein dimerization in mammalian membranes. J Am Chem Soc (2010) 1.45
Exercise training increases intramyocellular lipid and oxidative capacity in older adults. Am J Physiol Endocrinol Metab (2004) 1.41
Control of salicylic acid synthesis and systemic acquired resistance by two members of a plant-specific family of transcription factors. Proc Natl Acad Sci U S A (2010) 1.36
Spontaneous membrane-translocating peptides by orthogonal high-throughput screening. J Am Chem Soc (2011) 1.35
Hedgehog signaling is activated in subsets of esophageal cancers. Int J Cancer (2006) 1.34
The tiger genome and comparative analysis with lion and snow leopard genomes. Nat Commun (2013) 1.32
Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial. Chin J Cancer (2011) 1.32
Influence of solvent on the growth of ZnO nanoparticles. J Colloid Interface Sci (2003) 1.31
Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: analysis of the retinal nerve fiber layer map for glaucoma detection. Ophthalmology (2010) 1.30
Spatial regulation of Raf kinase signaling by RKTG. Proc Natl Acad Sci U S A (2007) 1.29
Rational combinatorial design of pore-forming beta-sheet peptides. Proc Natl Acad Sci U S A (2005) 1.28
Natural Anaplasma phagocytophilum infection of ticks and rodents from a forest area of Jilin Province, China. Am J Trop Med Hyg (2006) 1.28
The achondroplasia mutation does not alter the dimerization energetics of the fibroblast growth factor receptor 3 transmembrane domain. Biochemistry (2006) 1.28
Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol. Circ Cardiovasc Genet (2011) 1.27
Organizational and mutational analysis of a complete FR-008/candicidin gene cluster encoding a structurally related polyene complex. Chem Biol (2003) 1.27
Transmembrane helix dimerization: beyond the search for sequence motifs. Biochim Biophys Acta (2011) 1.26
Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer (2010) 1.25
Energetics of ErbB1 transmembrane domain dimerization in lipid bilayers. Biophys J (2009) 1.24
The extracellular domain of fibroblast growth factor receptor 3 inhibits ligand-independent dimerization. Sci Signal (2010) 1.22
Quantitative measurements of protein interactions in a crowded cellular environment. Anal Chem (2008) 1.21
Diabetogenic T-cell clones recognize an altered peptide of chromogranin A. Diabetes (2012) 1.20
PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. Am J Physiol Endocrinol Metab (2006) 1.18
Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB. PLoS One (2013) 1.18
Genome analysis and signature discovery for diving and sensory properties of the endangered Chinese alligator. Cell Res (2013) 1.18
Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis (2008) 1.17
Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J Virol (2005) 1.16
Programmed subcellular release for studying the dynamics of cell detachment. Nat Methods (2009) 1.15
Vibrational coupling, isotopic editing, and beta-sheet structure in a membrane-bound polypeptide. J Am Chem Soc (2004) 1.15
Pathogenic activation of receptor tyrosine kinases in mammalian membranes. J Mol Biol (2008) 1.15
Anticancer and chemosensitizing abilities of cycloviolacin 02 from Viola odorata and psyle cyclotides from Psychotria leptothyrsa. Biopolymers (2010) 1.13
Studies of receptor tyrosine kinase transmembrane domain interactions: the EmEx-FRET method. J Membr Biol (2007) 1.13
Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) (2011) 1.12
Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. PLoS One (2012) 1.12
Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes. Biochemistry (2007) 1.12
High-throughput discovery of broad-spectrum peptide antibiotics. FASEB J (2010) 1.11
Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One (2010) 1.10
The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med Genet (2011) 1.10
Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res (2010) 1.10
Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2. Neoplasia (2011) 1.09
The blood-brain barrier: an engineering perspective. Front Neuroeng (2013) 1.09
Increased expression of the integral membrane protein ErbB2 in Chinese hamster ovary cells expressing the anti-apoptotic gene Bcl-xL. Protein Expr Purif (2009) 1.09
Evaluating genetic risk for prostate cancer among Japanese and Latinos. Cancer Epidemiol Biomarkers Prev (2012) 1.08
Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ. Hepatology (2013) 1.08
Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo. J Immunol (2008) 1.08
The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels. Eur Heart J (2011) 1.07
Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes (2007) 1.07
Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis. J Rheumatol (2008) 1.07
Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes. Carcinogenesis (2013) 1.07
RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells. Carcinogenesis (2008) 1.07
Physical-chemical principles underlying RTK activation, and their implications for human disease. Biochim Biophys Acta (2011) 1.06
Transmembrane helix heterodimerization in lipid bilayers: probing the energetics behind autosomal dominant growth disorders. J Mol Biol (2006) 1.06
Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics. Cell Adh Migr (2010) 1.06
The skinny on Slug. Mol Carcinog (2010) 1.06
Synthesis and initial characterization of FGFR3 transmembrane domain: consequences of sequence modifications. Biochim Biophys Acta (2005) 1.06
Effect of pathogenic cysteine mutations on FGFR3 transmembrane domain dimerization in detergents and lipid bilayers. Biochemistry (2007) 1.05
Forster resonance energy transfer measurements of transmembrane helix dimerization energetics. Methods Enzymol (2008) 1.05
Imaging forster resonance energy transfer measurements of transmembrane helix interactions in lipid bilayers on a solid support. Langmuir (2004) 1.05
Association of obesity-related genetic variants with endometrial cancer risk: a report from the Shanghai Endometrial Cancer Genetics Study. Am J Epidemiol (2011) 1.05
A look at arginine in membranes. J Membr Biol (2010) 1.05
T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes (2004) 1.04
Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET. PLoS One (2012) 1.04
Isolation outcome and functional characteristics of young and adult pig pancreatic islets for transplantation studies. Xenotransplantation (2007) 1.02
Directed assembly of surface-supported bilayers with transmembrane helices. Langmuir (2006) 1.02
Harmful delayed effects of exogenous isolation enzymes on isolated human islets: relevance to clinical transplantation. Am J Transplant (2005) 1.01
LIN28 is selectively expressed by primordial and pre-meiotic germ cells in the human fetal ovary. Stem Cells Dev (2012) 1.01
A highly accurate statistical approach for the prediction of transmembrane beta-barrels. Bioinformatics (2010) 1.01